These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1002 related items for PubMed ID: 27602757

  • 1. Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells.
    Nagathihalli NS, Castellanos JA, VanSaun MN, Dai X, Ambrose M, Guo Q, Xiong Y, Merchant NB.
    Oncotarget; 2016 Oct 04; 7(40):65982-65992. PubMed ID: 27602757
    [Abstract] [Full Text] [Related]

  • 2. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
    Wu YS, Chung I, Wong WF, Masamune A, Sim MS, Looi CY.
    Biochim Biophys Acta Gen Subj; 2017 Feb 04; 1861(2):296-306. PubMed ID: 27750041
    [Abstract] [Full Text] [Related]

  • 3. Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice.
    He P, Yang JW, Yang VW, Bialkowska AB.
    Gastroenterology; 2018 Apr 04; 154(5):1494-1508.e13. PubMed ID: 29248441
    [Abstract] [Full Text] [Related]

  • 4. Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.
    Zhao W, Ajani JA, Sushovan G, Ochi N, Hwang R, Hafley M, Johnson RL, Bresalier RS, Logsdon CD, Zhang Z, Song S.
    Gastroenterology; 2018 Apr 04; 154(5):1524-1537.e6. PubMed ID: 29274868
    [Abstract] [Full Text] [Related]

  • 5. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
    Grünwald B, Harant V, Schaten S, Frühschütz M, Spallek R, Höchst B, Stutzer K, Berchtold S, Erkan M, Prokopchuk O, Martignoni M, Esposito I, Heikenwalder M, Gupta A, Siveke J, Saftig P, Knolle P, Wohlleber D, Krüger A.
    Gastroenterology; 2016 Nov 04; 151(5):1011-1024.e7. PubMed ID: 27506299
    [Abstract] [Full Text] [Related]

  • 6. IL-6/STAT3 Plays a Regulatory Role in the Interaction Between Pancreatic Stellate Cells and Cancer Cells.
    Hamada S, Masamune A, Yoshida N, Takikawa T, Shimosegawa T.
    Dig Dis Sci; 2016 Jun 04; 61(6):1561-71. PubMed ID: 26738736
    [Abstract] [Full Text] [Related]

  • 7. The P2X7 Receptor Stimulates IL-6 Release from Pancreatic Stellate Cells and Tocilizumab Prevents Activation of STAT3 in Pancreatic Cancer Cells.
    Magni L, Bouazzi R, Heredero Olmedilla H, Petersen PSS, Tozzi M, Novak I.
    Cells; 2021 Jul 29; 10(8):. PubMed ID: 34440697
    [Abstract] [Full Text] [Related]

  • 8. Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages.
    Incio J, Suboj P, Chin SM, Vardam-Kaur T, Liu H, Hato T, Babykutty S, Chen I, Deshpande V, Jain RK, Fukumura D.
    PLoS One; 2015 Jul 29; 10(12):e0141392. PubMed ID: 26641266
    [Abstract] [Full Text] [Related]

  • 9. Soluble factors from stellate cells induce pancreatic cancer cell proliferation via Nrf2-activated metabolic reprogramming and ROS detoxification.
    Wu YS, Looi CY, Subramaniam KS, Masamune A, Chung I.
    Oncotarget; 2016 Jun 14; 7(24):36719-36732. PubMed ID: 27167341
    [Abstract] [Full Text] [Related]

  • 10. Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer.
    Nagathihalli NS, Castellanos JA, Lamichhane P, Messaggio F, Shi C, Dai X, Rai P, Chen X, VanSaun MN, Merchant NB.
    Cancer Res; 2018 Nov 01; 78(21):6235-6246. PubMed ID: 30154150
    [Abstract] [Full Text] [Related]

  • 11. Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma.
    Ene-Obong A, Clear AJ, Watt J, Wang J, Fatah R, Riches JC, Marshall JF, Chin-Aleong J, Chelala C, Gribben JG, Ramsay AG, Kocher HM.
    Gastroenterology; 2013 Nov 01; 145(5):1121-32. PubMed ID: 23891972
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.
    Nagathihalli NS, Castellanos JA, Shi C, Beesetty Y, Reyzer ML, Caprioli R, Chen X, Walsh AJ, Skala MC, Moses HL, Merchant NB.
    Gastroenterology; 2015 Dec 01; 149(7):1932-1943.e9. PubMed ID: 26255562
    [Abstract] [Full Text] [Related]

  • 14. The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models.
    Shen R, Wang Q, Cheng S, Liu T, Jiang H, Zhu J, Wu Y, Wang L.
    Cancer Lett; 2013 Oct 01; 339(1):135-43. PubMed ID: 23887057
    [Abstract] [Full Text] [Related]

  • 15. Global targetome analysis reveals critical role of miR-29a in pancreatic stellate cell mediated regulation of PDAC tumor microenvironment.
    Dey S, Liu S, Factora TD, Taleb S, Riverahernandez P, Udari L, Zhong X, Wan J, Kota J.
    BMC Cancer; 2020 Jul 13; 20(1):651. PubMed ID: 32660466
    [Abstract] [Full Text] [Related]

  • 16. YAP1-mediated pancreatic stellate cell activation inhibits pancreatic cancer cell proliferation.
    Xiao Y, Zhang H, Ma Q, Huang R, Lu J, Liang X, Liu X, Zhang Z, Yu L, Pang J, Zhou L, Liu T, Wu H, Liang Z.
    Cancer Lett; 2019 Oct 10; 462():51-60. PubMed ID: 31352078
    [Abstract] [Full Text] [Related]

  • 17. Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma Tumors.
    Kang Y, Roife D, Lee Y, Lv H, Suzuki R, Ling J, Rios Perez MV, Li X, Dai B, Pratt M, Truty MJ, Chatterjee D, Wang H, Thomas RM, Wang Y, Koay EJ, Chiao PJ, Katz MH, Fleming JB.
    Clin Cancer Res; 2016 Oct 01; 22(19):4934-4946. PubMed ID: 27126993
    [Abstract] [Full Text] [Related]

  • 18. Tumor-neuroglia interaction promotes pancreatic cancer metastasis.
    Su D, Guo X, Huang L, Ye H, Li Z, Lin L, Chen R, Zhou Q.
    Theranostics; 2020 Oct 01; 10(11):5029-5047. PubMed ID: 32308766
    [Abstract] [Full Text] [Related]

  • 19. Targeting of the P2X7 receptor in pancreatic cancer and stellate cells.
    Giannuzzo A, Saccomano M, Napp J, Ellegaard M, Alves F, Novak I.
    Int J Cancer; 2016 Dec 01; 139(11):2540-52. PubMed ID: 27513892
    [Abstract] [Full Text] [Related]

  • 20. Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal adenocarcinoma.
    Maeda S, Kuboki S, Nojima H, Shimizu H, Yoshitomi H, Furukawa K, Miyazaki M, Ohtsuka M.
    Cytokine; 2017 Jul 01; 95():12-21. PubMed ID: 28214673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.